Hyphens Pharma International (SGX:1J5) ROCE % : 11.71% (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hyphens Pharma International's annualized ROCE % for the quarter that ended in Jun. 2023 was 11.71%.

Hyphens Pharma International ROCE % Historical Data

The historical data trend for Hyphens Pharma International's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International ROCE % Chart

Hyphens Pharma International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

23.51

18.75

14.71

15.50

22.18

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial										20.45	11.31	25.68	18.85	11.71

Hyphens Pharma International ROCE % Calculation

Hyphens Pharma International's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	14.529	/	( ( (99.191 - 42.557)	+	(114.469 - 40.074) )	/ 2 )
	=	14.529	/	( (56.634	+	74.395)	/ 2 )
	=	14.529	/	65.5145
	=	22.18 %

Hyphens Pharma International's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	8.682	/	( ( (114.469 - 40.074)	+	(115.331 - 41.486) )	/ 2 )
	=	8.682	/	( ( 74.395	+	73.845 )	/ 2 )
	=	8.682	/	74.12
	=	11.71 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Hyphens Pharma International (SGX:1J5) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hyphens Pharma International ROCE % Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Tai Seng Street, Level 4, Singapore, SGP, 534138

Website

https://www.hyphensgroup.com

Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines